©The Author(s) 2019.
World J Diabetes. Jan 15, 2019; 10(1): 1-15
Published online Jan 15, 2019. doi: 10.4239/wjd.v10.i1.1
Published online Jan 15, 2019. doi: 10.4239/wjd.v10.i1.1
Table 2 Biological, (patho)physiological and pharmacological factors influencing hemoglobin A1c
| Factor influencing HbA1c synthesis/measurement/interpretation |
| Age, ethnicity |
| Genetic factors (e.g. Glucose-6-phosphate dehydrogenase variants) |
| Pregnancy |
| Red blood cell lifespan |
| Haemolytic anaemia |
| Iron deficiency anaemia |
| Haemoglobin variants |
| Accute haemorrhage |
| Splenomegaly |
| Splenectomy |
| Transfusion |
| Chronic liver disease |
| End-stage renal disease |
| Rheumatoid arthritis |
| Vitamin C |
| Drugs (aspirin, erytropoietin, dapsone, antiretroviral agents) |
| Endogenous interferents (high levels of bilirubin/triglycerides) |
- Citation: Krhač M, Lovrenčić MV. Update on biomarkers of glycemic control. World J Diabetes 2019; 10(1): 1-15
- URL: https://www.wjgnet.com/1948-9358/full/v10/i1/1.htm
- DOI: https://dx.doi.org/10.4239/wjd.v10.i1.1